Login to Your Account



Financings roundup


Monday, February 24, 2014
Progenics Pharmaceuticals Inc., of Tarrytown, N.Y., priced its public offering of about 7.6 million shares at $4.60 per share, a 6 percent discount to Thursday’s closing price.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription